Radiation Recall Dermatitis after Donor Lymphocyte Infusion for Adult T-Cell Leukemia Lymphoma Post-Allogeneic Stem Cell Transplant.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 36347452.
- Also identified by DOI 10.1016/j.prro.2022.10.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To our knowledge, this is the first case report describing radiation recall dermatitis (RRD) after donor lymphocyte infusion post-allogeneic stem cell transplant in a patient with acute T-cell leukemia lymphoma. Given its rare occurrence, unclear clinical characterization, and etiology, RRD remains poorly understood. In the setting of novel immunotherapies and recent development of COVID-19 mRNA vaccines, we aimed to better characterize RRD and its most likely pathogenesis in our patient's case.
Medical subject headings
- Leukemia-Lymphoma, Adult T-Cell
- Hematopoietic Stem Cell Transplantation
- Graft vs Host Disease
- Radiodermatitis
- COVID-19